Journal of Commercial Biotechnology logo Palgrave Macmillan logo

Publisher: Palgrave Macmillan

Volume 12, Number 4, 1 July 2006
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial
pp. 253-253(1)
Author: Henderson, Neil

Valuing biotechnology companies using the price earnings ratio
pp. 254-260(7)
Authors: Loh, Jacqueline; Brooks, Robert

An overview of trends in multilateral environmental agreements with an impact on biotechnology and research in Asia and the Pacific
pp. 261-273(13)
Authors: Keller, Frankie; Macer, Darryl R J

What you give is what you get: Investment in European biotechnology
pp. 274-283(10)
Author: Bains, William

Ticking time bomb: Poorly managed product safety
pp. 284-293(10)
Authors: Meline, Greg; Albani, Chris

Cancer remains the dominant disease target for biotech through to 2010
pp. 294-298(5)
Authors: Pijpers, Fleur; Belsey, Mark J

Legal and regulatory update
pp. 299-311(13)

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A